1. Home
  2. FOLD vs BNL Comparison

FOLD vs BNL Comparison

Compare FOLD & BNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.19

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

HOLD

Current Price

$17.53

Market Cap

3.3B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
BNL
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
FOLD
BNL
Price
$14.19
$17.53
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$29.79
$19.86
AVG Volume (30 Days)
14.8M
2.3M
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
6.62%
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$598,704,000.00
$447,973,000.00
Revenue This Year
$21.49
$5.68
Revenue Next Year
$18.25
$7.27
P/E Ratio
N/A
$37.34
Revenue Growth
21.28
5.49
52 Week Low
$5.51
$13.96
52 Week High
$14.36
$18.87

Technical Indicators

Market Signals
Indicator
FOLD
BNL
Relative Strength Index (RSI) 91.10 44.27
Support Level $10.64 $17.34
Resistance Level $11.14 $17.91
Average True Range (ATR) 0.36 0.29
MACD 0.28 0.02
Stochastic Oscillator 96.46 45.39

Price Performance

Historical Comparison
FOLD
BNL

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

Share on Social Networks: